Joint Meeting of the
Pulmonary-Allergy Drugs Advisory Committee, Drug Safety & Risk Management
Advisory Committee, and the Pediatric Advisory Committee
December 11, 2008
SLIDES
FDA
Opening Remarks, Ann W. McMahon,
MD, MS, Acting Director, Division of Pharmacovigilance II, Office of
Surveillance and Epidemiology/CDER (pdf)
(html)
M. Dianne Murphy, M.D., Director,
Office of Pediatric Therapeutics, Office of the Commissioner (pdf) (html)
Badrul A. Chowdhury, MD, PhD, Director,
Division of Pulmonary and Allergy Products, OND/CDER (pdf) (html)
Ann W. McMahon, MD, MS, Acting
Director, Division of Pharmacovigilance II, Office of Surveillance and
Epidemiology/CDER (pdf) (html)
OPH
OPH #1 (pdf) (html)
Up
| AC Home Page